Invention Grant
- Patent Title: Cyanopyrimidine derivatives
-
Application No.: US16087354Application Date: 2017-03-22
-
Publication No.: US11261163B2Publication Date: 2022-03-01
- Inventor: Matthias Bremer , Atsutaka Manabe
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano and Branigan, P.C.
- Agent Harry B. Shubin
- Priority: EP16162306 20160324
- International Application: PCT/EP2017/056754 WO 20170322
- International Announcement: WO2017/162707 WO 20170928
- Main IPC: C09K19/06
- IPC: C09K19/06 ; C07D239/26 ; C09K19/18 ; C09K19/32 ; C09K19/34

Abstract:
The present invention relates to compounds of formula M in which RM has the meaning indicated in claim 1, to liquid crystal mixture comprising the same, to the use of these liquid-crystal media, in particular in components for high-frequency technology, and to components of this type which contain media according to the invention, and to the production and use of these components. The components according to the invention are suitable, in particular, as phase shifters in the microwave and millimetre wave region, for microwave and millimetre wave array antennae and very particularly for so-called tunable “reflectarrays”.
Public/Granted literature
- US20200262795A1 CYANOPYRIMIDINE DERIVATIVES Public/Granted day:2020-08-20
Information query